Blockbuster drug Humira finally faces lower-cost rivals
AbbVie's Humira was the world's best-selling drug for many years. Now it faces competition for copycats that cost a fraction of its price.David J. Phillip | AP Humira has…
AbbVie's Humira was the world's best-selling drug for many years. Now it faces competition for copycats that cost a fraction of its price.David J. Phillip | AP Humira has…